Literature DB >> 16928806

Development of polycystic kidney disease in juvenile cystic kidney mice: insights into pathogenesis, ciliary abnormalities, and common features with human disease.

Laurie A Smith1, Nikolay O Bukanov, Hervé Husson, Ryan J Russo, Tiffany C Barry, Ava L Taylor, David R Beier, Oxana Ibraghimov-Beskrovnaya.   

Abstract

Significant progress in understanding the molecular mechanisms of polycystic kidney disease (PKD) has been made in recent years. Translating this understanding into effective therapeutics will require testing in animal models that closely resemble human PKD by multiple parameters. Similar to autosomal dominant PKD, juvenile cystic kidney (jck) mice develop cysts in multiple nephron segments, including cortical collecting ducts, distal tubules, and loop of Henle. The jck mice display gender dimorphism in kidney disease progression with more aggressive disease in male mice. Gonadectomy experiments show that testosterone aggravates the severity of the disease in jck male mice, while female gonadal hormones have protective effects. EGF receptor is overexpressed and mislocalized in jck cystic epithelia, a hallmark of human disease. Increased cAMP levels in jck kidneys and activation of the B-Raf/extracellular signal-regulated kinase pathway are demonstrated. The effect of jck mutation on the expression of Nek8, a NIMA-related (never in mitosis A) kinase, and polycystins in jck cilia is shown for the first time. Nek8 overexpression and loss of ciliary localization in jck epithelia are accompanied by enhanced expression of polycystins along the cilia. The primary cilia in jck kidneys are significantly more lengthened than the cilia in wild-type mice, suggesting a role for Nek8 in controlling ciliary length. Collectively, these data demonstrate that the jck mice should be useful for testing potential therapies and for studying the molecular mechanisms that link ciliary structure/function and cystogenesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16928806     DOI: 10.1681/ASN.2006020136

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  93 in total

1.  Lipocalin 2 is essential for chronic kidney disease progression in mice and humans.

Authors:  Amandine Viau; Khalil El Karoui; Denise Laouari; Martine Burtin; Clément Nguyen; Kiyoshi Mori; Evangéline Pillebout; Thorsten Berger; Tak Wah Mak; Bertrand Knebelmann; Gérard Friedlander; Jonathan Barasch; Fabiola Terzi
Journal:  J Clin Invest       Date:  2010-11       Impact factor: 14.808

2.  2-Hydroxyestradiol slows progression of experimental polycystic kidney disease.

Authors:  Sharon Anderson; Terry T Oyama; Jessie N Lindsley; William E Schutzer; Douglas R Beard; Vincent H Gattone; Radko Komers
Journal:  Am J Physiol Renal Physiol       Date:  2011-12-07

Review 3.  Vasopressin and disruption of calcium signalling in polycystic kidney disease.

Authors:  Fouad T Chebib; Caroline R Sussman; Xiaofang Wang; Peter C Harris; Vicente E Torres
Journal:  Nat Rev Nephrol       Date:  2015-04-14       Impact factor: 28.314

4.  Somatostatin signaling in neuronal cilia is critical for object recognition memory.

Authors:  Emily B Einstein; Carlyn A Patterson; Beverly J Hon; Kathleen A Regan; Jyoti Reddi; David E Melnikoff; Marcus J Mateer; Stefan Schulz; Brian N Johnson; Melanie K Tallent
Journal:  J Neurosci       Date:  2010-03-24       Impact factor: 6.167

Review 5.  Autosomal dominant polycystic kidney disease: the last 3 years.

Authors:  Vicente E Torres; Peter C Harris
Journal:  Kidney Int       Date:  2009-05-20       Impact factor: 10.612

6.  Aberrant glycosylation and localization of polycystin-1 cause polycystic kidney in an AQP11 knockout model.

Authors:  Yuichi Inoue; Eisei Sohara; Katsuki Kobayashi; Motoko Chiga; Tatemitsu Rai; Kenichi Ishibashi; Shigeo Horie; Xuefeng Su; Jing Zhou; Sei Sasaki; Shinichi Uchida
Journal:  J Am Soc Nephrol       Date:  2014-05-22       Impact factor: 10.121

7.  Pkd1 transgenic mice: adult model of polycystic kidney disease with extrarenal and renal phenotypes.

Authors:  Almira Kurbegovic; Olivier Côté; Martin Couillard; Christopher J Ward; Peter C Harris; Marie Trudel
Journal:  Hum Mol Genet       Date:  2010-01-06       Impact factor: 6.150

8.  Ciliary and centrosomal defects associated with mutation and depletion of the Meckel syndrome genes MKS1 and MKS3.

Authors:  Rachaneekorn Tammachote; Cynthia J Hommerding; Rachel M Sinders; Caroline A Miller; Peter G Czarnecki; Amanda C Leightner; Jeffrey L Salisbury; Christopher J Ward; Vicente E Torres; Vincent H Gattone; Peter C Harris
Journal:  Hum Mol Genet       Date:  2009-06-10       Impact factor: 6.150

9.  Phosphodiesterase Isoform Regulation of Cell Proliferation and Fluid Secretion in Autosomal Dominant Polycystic Kidney Disease.

Authors:  Cibele S Pinto; Archana Raman; Gail A Reif; Brenda S Magenheimer; Corey White; James P Calvet; Darren P Wallace
Journal:  J Am Soc Nephrol       Date:  2015-08-19       Impact factor: 10.121

10.  Functional polycystin-1 dosage governs autosomal dominant polycystic kidney disease severity.

Authors:  Katharina Hopp; Christopher J Ward; Cynthia J Hommerding; Samih H Nasr; Han-Fang Tuan; Vladimir G Gainullin; Sandro Rossetti; Vicente E Torres; Peter C Harris
Journal:  J Clin Invest       Date:  2012-10-15       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.